Lack of involvement of retinoic acid receptor α in retinoid-induced skin irritation in hairless mice

Toxicology Letters

Volumn 92, Issue 3, 1997, Pages 231-240

  Standeven, Andrew M ^a   Teng, Min ^a   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

Author keywords

Hairless mice; RAR antagonist; RAR ; RAR ; Retinoic acid receptors; Retinoids; Skin irritation

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; AGN 193644; AGN 193835; AGN 193836; AGN 194301; BENZOIC ACID DERIVATIVE; RECEPTOR BLOCKING AGENT; RETINOIC ACID RECEPTOR; RETINOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN IRRITATION; SKIN TOXICITY; TOPICAL DRUG ADMINISTRATION;

ANIMALS; FEMALE; HUMANS; IRRITANTS; MICE; MICE, INBRED HRS; RECEPTORS, RETINOIC ACID; RETINOIDS; SKIN;

ANIMALIA;

EID: 0030757621     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00065-9     Document Type: Article

References (30)

1. Armstrong, R.B., Ashenfelter, K.O., Eckhoff, C., Levin, A.A., Shapiro, S.S., 1994. General and reproductive toxicology of retinoids. In: Sporn, M.B., Roberts, A.B. and Goodman, D.S., (Eds.), The Retinoids: Biology, Chemistry, and Medicine. Raven Press, New York, pp. 545-572.
2. Beehler, B.C., Chen, S., Tramposch, K.M., 1995. Gene expression of retinoic acid receptors and cellular retinoic acid-binding proteins in rhino and hairless mouse skin. Arch. Dermatol. Res. 287, 488-493.
3. Bernard, B.A., Bernardon, J.-M., Delescluse, C., Martin, B., Lenoir, M.C., Maignan, M., Charpentier, B., Pilgrim, W.R., Reichert, U., Shroot, B., 1992. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor 7. Biochem. Biophys. Res. Comm. 186, 977-983.
4. Boehm, M.F., Heyman, R.A., Patel, S., Stein, R.B., Nagpal, S., 1995. Retinoids: biological function and use in the treatment of dermatological diseases. Exp. Opin. Invest. Drugs 4, 593-612.
5. Chambon, P., 1995. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Horm. Res. 50, 317-332.
6. Chandraratna, R.A.S., Gillett, S.J., Song, T.K., Attard, J., Vuligonda, S., Garst, M.E., Arefieg, T., Gil, D.W., Wheeler, L., 1995. Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs. Bioorgan. Med. Chem. Lett. 5, 523-527.
7. Chen, S., Ostrowski, J., Whiting, G., Roalsvig, T., Hammer, L., Currier, S.J., Honeyman, J., Kwasniewski, B., Yu, K.-L., Sterzycki, R., Kim, C.U., Starrett, J., Mansuri, M., Reczek, P.R., 1995. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J. Invest. Dermatol. 104, 779-783.
8. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
9. Christensen, K., Estes, P.A., Onate, S.A., Beck, C.A., De-Marzo, A., Altmann, M., Lieberman, B.A., St John, J., Nordeen, S.K., Edwards, D.P. Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system, Mol. Endocrinol. 5, 1755-1770.
10. Delescluse, C., Cavey, M.T., Martin, B., Bernard, B.A., Reichert, U., Maignan, J., Darmon, M., Shroot, B., 1991. Selective high affinity retinoic acid receptor α or β-γ ligands. Mol. Pharmacol. 40, 556-562.
11. Draize, J.H., Woodard, G., Calvery, H.O., 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377-390.
12. Elder, J.T., Fisher, G.J., Quing-Yu, Z., Eisen, D., Krust, A., Kastner, P., Chambon, P., Voorhees, J.J., 1991. Retinoic acid receptor gene expression in human skin. J. Invest. Dermatol. 96, 425-433.
13. Elias, P.M., Fritsch, P.O., Lampe, M., Williams, M.L., Brown, B.E., Nemanic, M., Grayson, S., 1981. Retinoid effects on epidermal structure, differentiation, and permeability. Lab. Invest. 44, 531-540.
14. Esgleyes-Ribot, T., Chandraratna, R.A., Lew-Kaya, D.A., Sefton, J., Duvic, M., 1994. Response of psoriasis to a new topical retinoid, AGN 190168. J. Am. Acad. Dermatol. 30, 581-590.
15. Gollnick, H.P.M., 1996. Oral retinoids-efficacy and toxicity in psoriasis. Br. J. Dermatol. 135 (Suppl 49), 6-17.
16. Griffiths, C.E.M., Kang, S., Ellis, C.N., Kim, K.J., Finkel, L.J., Ortiz-Ferrer, L.C., White, G.M., Hamilton, T.A., Voorhees, J.J., 1995. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. Arch. Dermatol. 131, 1037-1044.
17. Johnson, A.T., Klein, E.S., Gillett, S.J., Wang, L., Song, T.K., Pino, M.E., Chandraratna, R.A.S., 1995. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 38, 4764-4767.
18. Johnson, A.T., Klein, E.S., Wang, L., Pino, M.E., Chandraratna, R.A.S., 1996. Identification of retinoic acid receptor β subtype specific agonists. J. Med. Chem. 39, 5027-5030.
19. Kagechika, H., Kawachi, E., Hashimoto, Y., Himi, T., Shudo, K., 1988. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem. 31, 2182-2192.
20. Kligman, L.H., Kligman, A.M., 1981. Histogenesis and progression of ultraviolet light-induced tumors in hairless mice. J. Natl. Cancer Inst. 67, 1289-1297.
21. Kovacs, J.A.J., Shear, N.H., 1993. Adverse non reproductive effects of retinoids in humans. In: G. Koren (Ed.), Retinoids in Clinical Practice: The Risk-Benefit Ratio, Marcel Dekker, New York, pp. 241-260.
22. Loeliger, P., Bollag, W., Mayer, H., 1980. Arotinoids, a new-class of highly active retinoids. Eur. J. Med. Chem. 15, 9-15.
23. 7-deficient mice to the toxic effects of retinoic acid. Am. J. Physiol. 269, E91-E98.
24. Mangelsdorf, D.J., Umesono, K., Evans, R.M., 1994. The retinoid receptors. In: Sporn, M.B., Roberts, A.B., Goodman, D.S. (Eds.), The Retinoids: Biology, Chemistry, and Medicine. Raven Press, New York, pp. 319-349.
25. Reczek, P.R., Ostrowski, J., Yu, K.-L., Chen, S., Hammer, L., Roalsvig, T., Starrett, J.E. Jr., Driscoll, J.P., Whiting, G., Spinazze, P.G., Tramposch, K.M., Mansuri, M.M., 1995. Role of retinoic acid receptor gamma in the rhino mouse and rabbit irritation models of retinoid activity. Skin Pharmacol. 8, 292-299.
26. Standeven, A.M., Johnson, A.T., Escobar, M., Chandraratna, R.A.S., 1996. Specific antagonist of retinoid toxicity in mice. Toxicol. Appl. Pharmacol. 138, 169-175.
27. Takeshita, A., Shibata, Y., Shinjo, K., Yanagi, M., Tobita, T., Ohnishi, K., Miyawaki, S., Shudo. K., Ohno, R., 1996. Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80. Ann. Intern. Med. 124, 893-896.
28. Teng, M., Duong, T.T., Klein, E.S., Pino, M.E., Chandraratna, R.A.S., 1996. Identification of a retinoic acid receptor a subtype specific agonist. J. Med. Chem. 39, 3035-3038.
29. Teng, M., Duong, T.T., Johnson, A.T., Klein, E.S., Wang, L., Khalifa, B., Pino, M.E., Chandraratna. R.A.S., 1997. Identification of highly potent retinoic acid receptor a selective antagonists. J, Med. Chem. (in press).
30. Thacher, S.M., Standeven, A.M., Athanikar, J., Kopper, S., Castilleja, O., Escobar, M., Beard, R.L., Chandraratna, R.A.S. Receptor specificity of retinoid-induced epidermal hyperplasia. Effect of RXR-selective agonists and correlation with topical irritation. J. Pharmacol. Exp. Therap. (in press).